Filter News
Area of Research
- (-) National Security (16)
- (-) Nuclear Science and Technology (7)
- Advanced Manufacturing (2)
- Biology and Environment (12)
- Clean Energy (21)
- Computational Engineering (1)
- Computer Science (3)
- Fusion and Fission (6)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (14)
- Materials (30)
- Materials for Computing (5)
- Neutron Science (48)
- Quantum information Science (1)
- Supercomputing (43)
News Type
News Topics
- (-) Advanced Reactors (4)
- (-) Artificial Intelligence (8)
- (-) Computer Science (11)
- (-) Isotopes (2)
- (-) Neutron Science (3)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (4)
- Bioenergy (2)
- Biology (2)
- Biomedical (2)
- Chemical Sciences (2)
- Climate Change (2)
- Cybersecurity (13)
- Decarbonization (1)
- Energy Storage (1)
- Environment (1)
- Exascale Computing (1)
- Frontier (1)
- Fusion (3)
- Grid (2)
- High-Performance Computing (1)
- Machine Learning (6)
- Materials (1)
- Materials Science (2)
- National Security (21)
- Nuclear Energy (13)
- Partnerships (4)
- Physics (3)
- Quantum Science (1)
- Security (7)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
- Transportation (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.